Exosome Derived Micro RNA: A Promising Modality in the Treatment of Spinal Cord Injury and Peripheral Neuropathy
- 10 May 2026
- journal article
- Published by Maad Rayan Publishing Company in Advanced Pharmaceutical Bulletin
- Vol. 16 (2) , 216-217
Abstract
Exosome Derived Micro RNA: A Promising Modality in the Treatment of Spinal Cord Injury and Peripheral NeuropathyKeywords
This publication has 7 references indexed in Scilit:
- Extracellular vesicle-derived MicroRNAs as potential therapies for spinal cord and peripheral nerve injuriesRNA Biology, 2025
- Neuropathic pain management: a focused review of current treatments and novel data from main ongoing clinical trialsExpert Opinion on Investigational Drugs, 2025
- The Therapeutic Potential of MicroRNA-21 in the Treatment of Spinal Cord InjuryCurrent Issues in Molecular Biology, 2025
- miR-146a-5p-modified hUCMSC-derived exosomes facilitate spinal cord function recovery by targeting neurotoxic astrocytesStem Cell Research & Therapy, 2022
- MiRNAs as Promising Translational Strategies for Neuronal Repair and Regeneration in Spinal Cord InjuryCells, 2022
- Neuron-derived exosomes-transmitted miR-124-3p protect traumatically injured spinal cord by suppressing the activation of neurotoxic microglia and astrocytesJournal of Nanobiotechnology, 2020
- Exosome-shuttled miR-216a-5p from hypoxic preconditioned mesenchymal stem cells repair traumatic spinal cord injury by shifting microglial M1/M2 polarizationJournal of Neuroinflammation, 2020